US4595061015 - Common Stock

We assign a fundamental rating of **3** out of 10 to **IFF**. **IFF** was compared to 83 industry peers in the **Chemicals** industry. **IFF** may be in some trouble as it scores bad on both profitability and health. **IFF** is quite expensive at the moment. It does show a decent growth rate.

In the past year **IFF** was profitable.

The reported net income has been mixed in the past 5 years: **IFF** reported negative net income in multiple years.

Each year in the past 5 years **IFF** had a positive operating cash flow.

With a **Return On Assets** value of **-8.15%**, **IFF** is not doing good in the industry: **85.54%** of the companies in the same industry are doing better.

With a **Return On Equity** value of **-17.47%**, **IFF** is not doing good in the industry: **80.72%** of the companies in the same industry are doing better.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -8.15% | ||

ROE | -17.47% | ||

ROIC | 1.71% |

ROA(3y)-4.29%

ROA(5y)-1.36%

ROE(3y)-8.95%

ROE(5y)-2.77%

ROIC(3y)1.88%

ROIC(5y)2.86%

In the last couple of years the **Operating Margin** of **IFF** has declined.

In the last couple of years the **Gross Margin** of **IFF** has declined.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 5.29% | ||

PM (TTM) | N/A | ||

GM | 32.96% |

OM growth 3Y-24.17%

OM growth 5Y-19.38%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-7.89%

GM growth 5Y-5.39%

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so **IFF** is destroying value.

The number of shares outstanding for **IFF** remains at a similar level compared to 1 year ago.

Compared to 5 years ago, **IFF** has more shares outstanding

Based on the Altman-Z score of **1.34**, we must say that **IFF** is in the distress zone and has some risk of bankruptcy.

The Debt to FCF ratio of **IFF** is **10.67**, which is on the high side as it means it would take **IFF**, **10.67** years of fcf income to pay off all of its debts.

A Debt/Equity ratio of **0.70** indicates that **IFF** is somewhat dependend on debt financing.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.7 | ||

Debt/FCF | 10.67 | ||

Altman-Z | 1.34 |

ROIC/WACC0.24

WACC7.07%

A Quick Ratio of **1.05** indicates that **IFF** should not have too much problems paying its short term obligations.

Looking at the **Quick ratio**, with a value of **1.05**, **IFF** is doing worse than **65.06%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 1.68 | ||

Quick Ratio | 1.05 |

Measured over the past years, **IFF** shows a very negative growth in **Earnings Per Share**. The EPS has been decreasing by **-11.67%** on average per year.

The **Revenue** has decreased by **-7.27%** in the past year.

EPS 1Y (TTM)-24.05%

EPS 3Y-16.32%

EPS 5Y-11.67%

EPS Q2Q%29.89%

Revenue 1Y (TTM)-7.27%

Revenue growth 3Y31.19%

Revenue growth 5Y23.61%

Sales Q2Q%-4.23%

Based on estimates for the next years, **IFF** will show a quite strong growth in **Earnings Per Share**. The EPS will grow by **11.11%** on average per year.

EPS Next Y21.23%

EPS Next 2Y15.39%

EPS Next 3Y14.16%

EPS Next 5Y11.11%

Revenue Next Year-2.68%

Revenue Next 2Y-0.68%

Revenue Next 3Y0.44%

Revenue Next 5Y1.03%

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

Compared to the rest of the industry, the **Price/Earnings** ratio of **IFF** is on the same level as its industry peers.

A **Price/Forward Earnings** ratio of **21.80** indicates a rather expensive valuation of **IFF**.

65.06% of the companies in the same industry are cheaper than **IFF**, based on the **Price/Forward Earnings** ratio.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 26.94 | ||

Fwd PE | 21.8 |

71.08% of the companies in the same industry are cheaper than **IFF**, based on the **Enterprise Value to EBITDA** ratio.

Compared to the rest of the industry, the **Price/Free Cash Flow** ratio of **IFF** is on the same level as its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 25.66 | ||

EV/EBITDA | 19.37 |

The **PEG Ratio(NY)**, which compensates the Price/Earnings for growth, indicates a correct valuation of the company.

PEG (NY)1.27

PEG (5Y)N/A

EPS Next 2Y15.39%

EPS Next 3Y14.16%

With a **Yearly Dividend Yield** of **1.64%**, **IFF** has a reasonable but not impressive dividend return.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.64% |

The dividend of **IFF** has a limited annual growth rate of **5.51%**.

Dividend Growth(5Y)5.51%

Div Incr Years21

Div Non Decr Years22

DP-33.13%

EPS Next 2Y15.39%

EPS Next 3Y14.16%

**INTL FLAVORS & FRAGRANCES**

NYSE:IFF (7/17/2024, 2:28:00 PM)

**96.9752**

**-1.13 (-1.16%) **

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap24.76B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.64% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 26.94 | ||

Fwd PE | 21.8 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)1.27

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -8.15% | ||

ROE | -17.47% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 5.29% | ||

PM (TTM) | N/A | ||

GM | 32.96% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.37

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.7 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 1.68 | ||

Quick Ratio | 1.05 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-24.05%

EPS 3Y-16.32%

EPS 5Y

EPS Q2Q%

EPS Next Y21.23%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-7.27%

Revenue growth 3Y31.19%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y